Type 1 diabetes is widely believed to be an autoimmune disorder, in which the body mistakenly attacks the pancreas’ own insulin-producing beta cells. If this is the case, immunotherapy could potentially be used to treat it, yet few trials to date have examined its potential. A new trial from researchers in the UK has investigated […]
Dr. Sheri Colberg, an exercise physiologist and diabetes educator, has herself been living with type 1 diabetes for nearly 50 years. She shares what has led to her success in managing her diabetes: her decision to be physically active, and making “a conscious choice to live my life by one guiding principle: Live life first, […]
People with type 1 are living longer, and the complications of type 1 are taking longer to appear, according to the Joslin 50-Year Medalist Study. The study examines over 900 people who have had type 1 for at least 50 years. Researchers cite good blood glucose control and exercise as key factors in helping these […]
A new analysis of past research finds erectile dysfunction (ED) affects 53 percent of men with diabetes. The study looked at data for nearly 90,000 men and found that those with diabetes are three and a half times more likely than men without the disease to experience ED. In addition to the sexual issue itself, ED can be a […]
A prototype vaccine will soon be ready for a clinical trial in humans, after two decades of research at the University of Tampere in Finland. Researchers have found evidence linking a type of virus called coxsackievirus B1 with an autoimmune reaction that causes the body to destroy its own pancreatic cells. The vaccine, if successful, […]
Certain intestinal viruses can affect a child’s chances of developing type 1 diabetes, according to researchers. Children with less diverse gut viral communities are more likely to generate self-destructive antibodies that can lead to type 1, while children who carried a specific virus belonging to the Circoviridae family were less likely to develop diabetes than those […]
People with both type 1 and type 2 diabetes are at greater risk of cognitive impairment, including dementia, than those without diabetes. One of the main reasons is the damage diabetes causes to small blood vessels. Exercise, in addition to being good for physical health, can help brain health. Read more
Study of people type 1 who donated organs for research has found high rates of suicide and the use of illegal drugs. While those who chose to donate may not be representative of all people with type 1, researchers argue the findings speak to the need for better emotional and psychological support resources for people coping […]
Type 1 diabetes used to be called “juvenile diabetes” and is often associated with children, while type 2 is more commonly associated with those middle-aged or older. But children with type 1 grow to be adults, and now type 2 is growing more common among the young. What are the differences and similarities in how type 1 […]
When gifted Irish cyclist Stephen Clancy was diagnosed with type 1 diabetes, he thought it might mean the end of his racing career. In the hospital, a diabetes consultant told him extreme levels of exercise could complicate his diabetes management and make it more difficult to control the condition. But then he found Team Novo […]
The A1C test is a standard way of diagnosing diabetes, by assessing the average levels of glucose attached to red blood cells. However, various genetic factors can affect the accuracy of the test’s results. Now, a new study in patients with type 1 shows that the tests are likely to overestimate the glucose levels of […]
A new study has discovered that beta cells have numerous vitamin A receptors. Tests show that partially blocking these vitamin A receptors affects insulin production, and completely blocking them can cause cell death. This suggests a vitamin A deficiency could be a factor in type 1 diabetes. Read more
Gleevec, a drug used to treat leukemia, may also slow the progression of type 1 diabetes. In a new study, the drug appeared to boost insulin production in the study participants’ bodies. While this study was conducted in adults, the researchers’ goal is to obtain FDA approval to test children, as the greatest potential for […]
Researchers have examined the apparent link between type 1 and asthma many times, but results have been inconclusive. Now a new study from Finland offers tantalizing new findings, but the complexity of the relationship between the two conditions has only deepened. In the study, children with a previous diagnosis of type 1 had a lower […]
An old and inexpensive vaccine may offer a cure for type 1 diabetes. BCG, a tuberculosis vaccine used worldwide, “Can reset the immune system to a normal state. It can get you back to normal levels of blood sugar,” according to Dr. Denise L. Faustman, who has launched a 5-year clinical trial to study BCG’s effect […]
The pilot study of a new “vaccine” for type 1 has yielded disappointing results so far, with children who received the vaccine no less likely to develop type 1 than children in the control group, researchers announced. However, researchers plan to test additional combinations of the formulation, and have not ruled out hope. Read more
Being diagnosed with type 1 diabetes at the age of 15 didn’t stop Romain Gioux from pursuing his dream. Now he competes professionally as part of Team Novo Nordisk, a group of elite athletes who haven’t let their diabetes diagnoses slow them down.
Cardiovascular disease is the leading cause of death in people with type 1 diabetes. A new study suggests that just one additional injection of insulin three hours after eating could provide protection. Read more
JDRF, formerly known as the Juvenile Diabetes Research Foundation, has launched a new campaign aimed at adovating for better insurance coverage for Americans with type 1 diabetes. The campaign, called Coverage2Control, is aimed at the many people with type 1 who are facing healthcare uncertainties and concerns about treatment choices, particularly with the current controversy […]
ViaCyte has obtained $10 million in financing to fund the clinical development of its stem cell-derived treatment for type 1 diabetes. The treatment uses stem cell-derived pancreatic cells in an implantable device. The cells are designed to mature into human pancreatic cells, including insulin-secreting beta cells. Read more